Global Oncology Immunotherapy Market Growth (Status and Outlook) 2022-2028
- LP 4881076
- 88 Pages
- March 2022
- Pharmaceuticals
The United States Oncology Immunotherapy market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Oncology Immunotherapy market, reaching US$ million by the year 2028. As for the Europe Oncology Immunotherapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Oncology Immunotherapy players cover Bristol-Myers Squibb, Merck & Co, Roche AG, and AstraZeneca, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Oncology Immunotherapy market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Immune Checkpoint Inhibitors
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospitals
Drugstores
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Bristol-Myers Squibb
Merck & Co
Roche AG
AstraZeneca
Sanofi S.A.
Dendreon Pharmaceuticals
Novartis
Gilead Sciences Inc.
Merck KGaA
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oncology Immunotherapy Market Size 2017-2028
2.1.2 Oncology Immunotherapy Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Oncology Immunotherapy Segment by Type
2.2.1 Immune Checkpoint Inhibitors
2.2.2 Cytokine-Based Immunotherapy
2.2.3 Cancer Vaccines
2.2.4 CAR-T Cell Therapy
2.2.5 Other
2.3 Oncology Immunotherapy Market Size by Type
2.3.1 Oncology Immunotherapy Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Oncology Immunotherapy Market Size Market Share by Type (2017-2022)
2.4 Oncology Immunotherapy Segment by Application
2.4.1 Hospitals
2.4.2 Drugstores
2.4.3 Others
2.5 Oncology Immunotherapy Market Size by Application
2.5.1 Oncology Immunotherapy Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Oncology Immunotherapy Market Size Market Share by Application (2017-2022)
3 Oncology Immunotherapy Market Size by Player
3.1 Oncology Immunotherapy Market Size Market Share by Players
3.1.1 Global Oncology Immunotherapy Revenue by Players (2020-2022)
3.1.2 Global Oncology Immunotherapy Revenue Market Share by Players (2020-2022)
3.2 Global Oncology Immunotherapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Oncology Immunotherapy by Regions
4.1 Oncology Immunotherapy Market Size by Regions (2017-2022)
4.2 Americas Oncology Immunotherapy Market Size Growth (2017-2022)
4.3 APAC Oncology Immunotherapy Market Size Growth (2017-2022)
4.4 Europe Oncology Immunotherapy Market Size Growth (2017-2022)
4.5 Middle East & Africa Oncology Immunotherapy Market Size Growth (2017-2022)
5 Americas
5.1 Americas Oncology Immunotherapy Market Size by Country (2017-2022)
5.2 Americas Oncology Immunotherapy Market Size by Type (2017-2022)
5.3 Americas Oncology Immunotherapy Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncology Immunotherapy Market Size by Region (2017-2022)
6.2 APAC Oncology Immunotherapy Market Size by Type (2017-2022)
6.3 APAC Oncology Immunotherapy Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Oncology Immunotherapy by Country (2017-2022)
7.2 Europe Oncology Immunotherapy Market Size by Type (2017-2022)
7.3 Europe Oncology Immunotherapy Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oncology Immunotherapy by Region (2017-2022)
8.2 Middle East & Africa Oncology Immunotherapy Market Size by Type (2017-2022)
8.3 Middle East & Africa Oncology Immunotherapy Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Oncology Immunotherapy Market Forecast
10.1 Global Oncology Immunotherapy Forecast by Regions (2023-2028)
10.1.1 Global Oncology Immunotherapy Forecast by Regions (2023-2028)
10.1.2 Americas Oncology Immunotherapy Forecast
10.1.3 APAC Oncology Immunotherapy Forecast
10.1.4 Europe Oncology Immunotherapy Forecast
10.1.5 Middle East & Africa Oncology Immunotherapy Forecast
10.2 Americas Oncology Immunotherapy Forecast by Country (2023-2028)
10.2.1 United States Oncology Immunotherapy Market Forecast
10.2.2 Canada Oncology Immunotherapy Market Forecast
10.2.3 Mexico Oncology Immunotherapy Market Forecast
10.2.4 Brazil Oncology Immunotherapy Market Forecast
10.3 APAC Oncology Immunotherapy Forecast by Region (2023-2028)
10.3.1 China Oncology Immunotherapy Market Forecast
10.3.2 Japan Oncology Immunotherapy Market Forecast
10.3.3 Korea Oncology Immunotherapy Market Forecast
10.3.4 Southeast Asia Oncology Immunotherapy Market Forecast
10.3.5 India Oncology Immunotherapy Market Forecast
10.3.6 Australia Oncology Immunotherapy Market Forecast
10.4 Europe Oncology Immunotherapy Forecast by Country (2023-2028)
10.4.1 Germany Oncology Immunotherapy Market Forecast
10.4.2 France Oncology Immunotherapy Market Forecast
10.4.3 UK Oncology Immunotherapy Market Forecast
10.4.4 Italy Oncology Immunotherapy Market Forecast
10.4.5 Russia Oncology Immunotherapy Market Forecast
10.5 Middle East & Africa Oncology Immunotherapy Forecast by Region (2023-2028)
10.5.1 Egypt Oncology Immunotherapy Market Forecast
10.5.2 South Africa Oncology Immunotherapy Market Forecast
10.5.3 Israel Oncology Immunotherapy Market Forecast
10.5.4 Turkey Oncology Immunotherapy Market Forecast
10.5.5 GCC Countries Oncology Immunotherapy Market Forecast
10.6 Global Oncology Immunotherapy Forecast by Type (2023-2028)
10.7 Global Oncology Immunotherapy Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Information
11.1.2 Bristol-Myers Squibb Oncology Immunotherapy Product Offered
11.1.3 Bristol-Myers Squibb Oncology Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Bristol-Myers Squibb Main Business Overview
11.1.5 Bristol-Myers Squibb Latest Developments
11.2 Merck & Co
11.2.1 Merck & Co Company Information
11.2.2 Merck & Co Oncology Immunotherapy Product Offered
11.2.3 Merck & Co Oncology Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Merck & Co Main Business Overview
11.2.5 Merck & Co Latest Developments
11.3 Roche AG
11.3.1 Roche AG Company Information
11.3.2 Roche AG Oncology Immunotherapy Product Offered
11.3.3 Roche AG Oncology Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Roche AG Main Business Overview
11.3.5 Roche AG Latest Developments
11.4 AstraZeneca
11.4.1 AstraZeneca Company Information
11.4.2 AstraZeneca Oncology Immunotherapy Product Offered
11.4.3 AstraZeneca Oncology Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 AstraZeneca Main Business Overview
11.4.5 AstraZeneca Latest Developments
11.5 Sanofi S.A.
11.5.1 Sanofi S.A. Company Information
11.5.2 Sanofi S.A. Oncology Immunotherapy Product Offered
11.5.3 Sanofi S.A. Oncology Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Sanofi S.A. Main Business Overview
11.5.5 Sanofi S.A. Latest Developments
11.6 Dendreon Pharmaceuticals
11.6.1 Dendreon Pharmaceuticals Company Information
11.6.2 Dendreon Pharmaceuticals Oncology Immunotherapy Product Offered
11.6.3 Dendreon Pharmaceuticals Oncology Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Dendreon Pharmaceuticals Main Business Overview
11.6.5 Dendreon Pharmaceuticals Latest Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Oncology Immunotherapy Product Offered
11.7.3 Novartis Oncology Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Novartis Main Business Overview
11.7.5 Novartis Latest Developments
11.8 Gilead Sciences Inc.
11.8.1 Gilead Sciences Inc. Company Information
11.8.2 Gilead Sciences Inc. Oncology Immunotherapy Product Offered
11.8.3 Gilead Sciences Inc. Oncology Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Gilead Sciences Inc. Main Business Overview
11.8.5 Gilead Sciences Inc. Latest Developments
11.9 Merck KGaA
11.9.1 Merck KGaA Company Information
11.9.2 Merck KGaA Oncology Immunotherapy Product Offered
11.9.3 Merck KGaA Oncology Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Merck KGaA Main Business Overview
11.9.5 Merck KGaA Latest Developments
12 Research Findings and Conclusion
Table 1. Oncology Immunotherapy Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Immune Checkpoint Inhibitors
Table 3. Major Players of Cytokine-Based Immunotherapy
Table 4. Major Players of Cancer Vaccines
Table 5. Major Players of CAR-T Cell Therapy
Table 6. Major Players of Other
Table 7. Oncology Immunotherapy Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Oncology Immunotherapy Market Size by Type (2017-2022) & ($ Millions)
Table 9. Global Oncology Immunotherapy Market Size Market Share by Type (2017-2022)
Table 10. Oncology Immunotherapy Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 11. Global Oncology Immunotherapy Market Size by Application (2017-2022) & ($ Millions)
Table 12. Global Oncology Immunotherapy Market Size Market Share by Application (2017-2022)
Table 13. Global Oncology Immunotherapy Revenue by Players (2020-2022) & ($ Millions)
Table 14. Global Oncology Immunotherapy Revenue Market Share by Player (2020-2022)
Table 15. Oncology Immunotherapy Key Players Head office and Products Offered
Table 16. Oncology Immunotherapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Oncology Immunotherapy Market Size by Regions 2017-2022 & ($ Millions)
Table 20. Global Oncology Immunotherapy Market Size Market Share by Regions (2017-2022)
Table 21. Americas Oncology Immunotherapy Market Size by Country (2017-2022) & ($ Millions)
Table 22. Americas Oncology Immunotherapy Market Size Market Share by Country (2017-2022)
Table 23. Americas Oncology Immunotherapy Market Size by Type (2017-2022) & ($ Millions)
Table 24. Americas Oncology Immunotherapy Market Size Market Share by Type (2017-2022)
Table 25. Americas Oncology Immunotherapy Market Size by Application (2017-2022) & ($ Millions)
Table 26. Americas Oncology Immunotherapy Market Size Market Share by Application (2017-2022)
Table 27. APAC Oncology Immunotherapy Market Size by Region (2017-2022) & ($ Millions)
Table 28. APAC Oncology Immunotherapy Market Size Market Share by Region (2017-2022)
Table 29. APAC Oncology Immunotherapy Market Size by Type (2017-2022) & ($ Millions)
Table 30. APAC Oncology Immunotherapy Market Size Market Share by Type (2017-2022)
Table 31. APAC Oncology Immunotherapy Market Size by Application (2017-2022) & ($ Millions)
Table 32. APAC Oncology Immunotherapy Market Size Market Share by Application (2017-2022)
Table 33. Europe Oncology Immunotherapy Market Size by Country (2017-2022) & ($ Millions)
Table 34. Europe Oncology Immunotherapy Market Size Market Share by Country (2017-2022)
Table 35. Europe Oncology Immunotherapy Market Size by Type (2017-2022) & ($ Millions)
Table 36. Europe Oncology Immunotherapy Market Size Market Share by Type (2017-2022)
Table 37. Europe Oncology Immunotherapy Market Size by Application (2017-2022) & ($ Millions)
Table 38. Europe Oncology Immunotherapy Market Size Market Share by Application (2017-2022)
Table 39. Middle East & Africa Oncology Immunotherapy Market Size by Region (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Oncology Immunotherapy Market Size Market Share by Region (2017-2022)
Table 41. Middle East & Africa Oncology Immunotherapy Market Size by Type (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Oncology Immunotherapy Market Size Market Share by Type (2017-2022)
Table 43. Middle East & Africa Oncology Immunotherapy Market Size by Application (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Oncology Immunotherapy Market Size Market Share by Application (2017-2022)
Table 45. Key Market Drivers & Growth Opportunities of Oncology Immunotherapy
Table 46. Key Market Challenges & Risks of Oncology Immunotherapy
Table 47. Key Industry Trends of Oncology Immunotherapy
Table 48. Global Oncology Immunotherapy Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 49. Global Oncology Immunotherapy Market Size Market Share Forecast by Regions (2023-2028)
Table 50. Global Oncology Immunotherapy Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 51. Global Oncology Immunotherapy Market Size Market Share Forecast by Type (2023-2028)
Table 52. Global Oncology Immunotherapy Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 53. Global Oncology Immunotherapy Market Size Market Share Forecast by Application (2023-2028)
Table 54. Bristol-Myers Squibb Details, Company Type, Oncology Immunotherapy Area Served and Its Competitors
Table 55. Bristol-Myers Squibb Oncology Immunotherapy Product Offered
Table 56. Bristol-Myers Squibb Oncology Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 57. Bristol-Myers Squibb Main Business
Table 58. Bristol-Myers Squibb Latest Developments
Table 59. Merck & Co Details, Company Type, Oncology Immunotherapy Area Served and Its Competitors
Table 60. Merck & Co Oncology Immunotherapy Product Offered
Table 61. Merck & Co Main Business
Table 62. Merck & Co Oncology Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 63. Merck & Co Latest Developments
Table 64. Roche AG Details, Company Type, Oncology Immunotherapy Area Served and Its Competitors
Table 65. Roche AG Oncology Immunotherapy Product Offered
Table 66. Roche AG Main Business
Table 67. Roche AG Oncology Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 68. Roche AG Latest Developments
Table 69. AstraZeneca Details, Company Type, Oncology Immunotherapy Area Served and Its Competitors
Table 70. AstraZeneca Oncology Immunotherapy Product Offered
Table 71. AstraZeneca Main Business
Table 72. AstraZeneca Oncology Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 73. AstraZeneca Latest Developments
Table 74. Sanofi S.A. Details, Company Type, Oncology Immunotherapy Area Served and Its Competitors
Table 75. Sanofi S.A. Oncology Immunotherapy Product Offered
Table 76. Sanofi S.A. Main Business
Table 77. Sanofi S.A. Oncology Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 78. Sanofi S.A. Latest Developments
Table 79. Dendreon Pharmaceuticals Details, Company Type, Oncology Immunotherapy Area Served and Its Competitors
Table 80. Dendreon Pharmaceuticals Oncology Immunotherapy Product Offered
Table 81. Dendreon Pharmaceuticals Main Business
Table 82. Dendreon Pharmaceuticals Oncology Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 83. Dendreon Pharmaceuticals Latest Developments
Table 84. Novartis Details, Company Type, Oncology Immunotherapy Area Served and Its Competitors
Table 85. Novartis Oncology Immunotherapy Product Offered
Table 86. Novartis Main Business
Table 87. Novartis Oncology Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 88. Novartis Latest Developments
Table 89. Gilead Sciences Inc. Details, Company Type, Oncology Immunotherapy Area Served and Its Competitors
Table 90. Gilead Sciences Inc. Oncology Immunotherapy Product Offered
Table 91. Gilead Sciences Inc. Main Business
Table 92. Gilead Sciences Inc. Oncology Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 93. Gilead Sciences Inc. Latest Developments
Table 94. Merck KGaA Details, Company Type, Oncology Immunotherapy Area Served and Its Competitors
Table 95. Merck KGaA Oncology Immunotherapy Product Offered
Table 96. Merck KGaA Main Business
Table 97. Merck KGaA Oncology Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 98. Merck KGaA Latest Developments
List of Figures
Figure 1. Oncology Immunotherapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oncology Immunotherapy Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Oncology Immunotherapy Market Size Market Share by Type in 2021
Figure 7. Oncology Immunotherapy in Hospitals
Figure 8. Global Oncology Immunotherapy Market: Hospitals (2017-2022) & ($ Millions)
Figure 9. Oncology Immunotherapy in Drugstores
Figure 10. Global Oncology Immunotherapy Market: Drugstores (2017-2022) & ($ Millions)
Figure 11. Oncology Immunotherapy in Others
Figure 12. Global Oncology Immunotherapy Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Oncology Immunotherapy Market Size Market Share by Application in 2021
Figure 14. Global Oncology Immunotherapy Revenue Market Share by Player in 2021
Figure 15. Global Oncology Immunotherapy Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Oncology Immunotherapy Market Size 2017-2022 ($ Millions)
Figure 17. APAC Oncology Immunotherapy Market Size 2017-2022 ($ Millions)
Figure 18. Europe Oncology Immunotherapy Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Oncology Immunotherapy Market Size 2017-2022 ($ Millions)
Figure 20. Americas Oncology Immunotherapy Value Market Share by Country in 2021
Figure 21. Americas Oncology Immunotherapy Consumption Market Share by Type in 2021
Figure 22. Americas Oncology Immunotherapy Market Size Market Share by Application in 2021
Figure 23. United States Oncology Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Oncology Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Oncology Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Oncology Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Oncology Immunotherapy Market Size Market Share by Region in 2021
Figure 28. APAC Oncology Immunotherapy Market Size Market Share by Application in 2021
Figure 29. China Oncology Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Oncology Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Oncology Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Oncology Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Oncology Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Oncology Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Oncology Immunotherapy Market Size Market Share by Country in 2021
Figure 36. Europe Oncology Immunotherapy Market Size Market Share by Type in 2021
Figure 37. Europe Oncology Immunotherapy Market Size Market Share by Application in 2021
Figure 38. Germany Oncology Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Oncology Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Oncology Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Oncology Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Oncology Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Oncology Immunotherapy Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Oncology Immunotherapy Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Oncology Immunotherapy Market Size Market Share by Application in 2021
Figure 46. Egypt Oncology Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Oncology Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Oncology Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Oncology Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Oncology Immunotherapy Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Oncology Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 52. APAC Oncology Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 53. Europe Oncology Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Oncology Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 55. United States Oncology Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 56. Canada Oncology Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Oncology Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Oncology Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 59. China Oncology Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 60. Japan Oncology Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 61. Korea Oncology Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Oncology Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 63. India Oncology Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 64. Australia Oncology Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 65. Germany Oncology Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 66. France Oncology Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 67. UK Oncology Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 68. Italy Oncology Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 69. Russia Oncology Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 70. Spain Oncology Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Oncology Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Oncology Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 73. Israel Oncology Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Oncology Immunotherapy Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Oncology Immunotherapy Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
